Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Aisling Capital Iii Lp

Affiliations

  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2018-07-12
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
  • Other at Transenterix Inc. (TRXC), 2016-02-05
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-12-09
  • Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
  • Large Shareholder at Zeltiq Aesthetics Inc (ZLTQ), 2014-01-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LOXO $31.00 160,000 Large Shareholder 4,188,920 2017-01-10 Filing
SYRS $12.50 400,000 Large Shareholder 908,565 2016-07-06 Filing
LOXO $21.50 232,558 Large Shareholder 4,028,920 2016-05-17 Filing
LOXO $27.50 200 Large Shareholder 3,796,362 2015-12-11 Filing
TTOO $9.75 307,692 Large Shareholder 2,830,992 2015-12-09 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LOXO $179.43 1,400,000 Large Shareholder 2,038,920 2018-07-10 Filing
LOXO $80.50 250,000 Large Shareholder 3,438,920 2017-12-19 Filing
LOXO $75.00 500,000 Large Shareholder 3,688,920 2017-11-22 Filing
DRTX $15.57 2,649 Large Shareholder 3,030,175 2014-03-21 Filing
DRTX $15.74 98,000 Large Shareholder 3,032,824 2014-03-20 Filing